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Hyperkinesias are heterogeneous conditions that share the feature of production of invol-
untary, abnormal, excessive movements. Tremor, dystonia, and chorea are amongst the
most common of these phenomena. In this focused review there is a discussion of dif-
ficult issues in hyperkinesias. The first one is the differential diagnosis between essential
tremor (ET) and Parkinson’s disease (PD). They are readily distinguishable in the majority
of patients but in a few subjects ET coexist with parkinsonian features whose underly-
ing mechanism remains to be determined. The second topic of the review is dystonic
tremor. Although increasingly diagnosed and reported as accounting for the majority of
scans without evidence of dopaminergic deficits, its diagnostic criteria are ill-defined and
differentiation from PD and ET can be challenging. In the last section, there is a discussion
of the differential diagnosis of Sydenham’s chorea (SC), the most common cause of chorea
in children. In a few patients, vascular disease, systemic lupus erythematosus, and primary
antiphospholipid antibody syndrome can mimic SC.
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INTRODUCTION
The term “hyperkinetic disorders” encompasses a large num-
ber of heterogeneous conditions that share the feature of pro-
duction of involuntary, abnormal, excessive movements. The
aim of this article is to discuss problems related to the diag-
nosis of some of the disorders meeting this inclusion cri-
terion. Given the wide variety of hyperkinetic disorders, the
author has made a choice of topics to be tackled, which can
be regarded as arbitrary but they represent issues that have
been source of diagnostic controversy in the recent litera-
ture.
Tremor is defined as a movement disorder characterized by
oscillatory, often rhythmic movement resulting from alternat-
ing contraction of muscles. There is consensus that it is the
most common movement disorder in population-based studied,
although the majority of patients attending movement disorders
units have the diagnosis of parkinsonism (Fahn and Jankovic,
2007). In the field of tremor, this article will discuss the contro-
versial relationship between essential tremor (ET) and Parkin-
son’s disease (PD). Abnormal postures and/or twisted move-
ments produced by repetitive and patterned muscle contractions
are the definition of dystonia (Fahn and Jankovic, 2007). In
the last few years, the term “dystonic tremor” has been used
to describe a condition about which there is a rather exten-
sive body of work. One of the aims of this article is to dis-
cuss the definition and diagnosis of dystonic tremor. Chorea is
a word derived from the Greek term to refer to dance. This
is an apt choice of terminology since the continuous and ran-
dom flow of muscle contractions that characterize chorea gives
this movement disorder an appearance of dance (Cardoso et al.,
2006).
DIFFERENTIATION BETWEEN ESSENTIAL TREMOR AND
PARKINSON’S DISEASE
The current definition of ET developed by the Movement Disor-
ders Society states that patients have bilateral postural or kinetic
tremor involving hands and forearms that is visible and persistent
and/or tremor of the head without abnormal posturing. Exclusion
criteria are other abnormal neurological signs (especially dysto-
nia), presence of known causes of enhanced physiological tremor,
evidence of psychogenic tremor, convincing evidence of sudden
onset or evidence of stepwise deterioration, primary orthostatic
tremor, isolated voice tremor, isolated position-specific or task-
specific tremors, isolated tongue or chin tremor, and isolated leg
tremor (Deuschl et al., 1998). In contrast, according to the Queen
Square Brain Bank, the most commonly used set of diagnostic
criteria of PD, the latter is diagnosed when the patient has bradyki-
nesia and at least one of following cardinal signs of parkinsonism:
rigidity, tremor, and postural instability, in the absence of a long
list of exclusion criteria. Furthermore, there are additional sup-
portive features, of which the most important one is response to
l-DOPA (Gibb and Lees, 1998).
Strictly considering these two definitions, there is little reason
to believe that there might be difficulties in distinguishing ET from
PD. In fact, in most cases the differential diagnosis is readily made.
As it has been described in many recent reviews, most authors
lean toward the opinion that there is no relationship between the
two conditions (Adler et al., 2011). This is supported by the lack
of shared clinical features (e.g., olfaction is normal in ET and
reduced in PD; sleep abnormalities, such as REM sleep behavioral
disorder is not present in ET); genetic markers (genes associated
to PD are unrelated to ET and vice-versa); pathological findings
(synucleinopathy is not found in ET subjects); and therapeutic
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response (Adler et al., 2011; Fekete and Jankovic, 2011). Neverthe-
less, epidemiological data suggest that there might be a relationship
between ET and PD (La Roia and Louis, 2011), although some
argue that this is due to inappropriate diagnosis of the former.
There are, however, few instances where the distinction is not
clear-cut. The most common source of problem are patients with
a longstanding history of action tremor, improvement with use
of ethanol, and family history of a similar condition who later in
life develop worsening of the condition with onset of rest tremor
and bradykinesia (Fekete and Jankovic, 2011). Conversely, patients
with PD who present with prominent postural and kinetic tremor
blur the clinical distinction between PD and ET. Even those who
do not believe there is a relationship between ET and PD concede
that these patients point out to the existence of a link between
the two conditions (Adler et al., 2011). However, although clini-
cally these patients meet criteria of both PD and ET, post mortem
studies of a few of them have failed to demonstrate that there
is underlying Lewy body pathology (Louis et al., 2011). One can
conclude, thus, that a few patients with long history of ET even-
tually develop parkinsonism but not PD. It remains, thus, to be
elucidated the mechanism underlying the parkinsonian findings
of these patients. In clinical practice, there are a few points that
need to be kept in mind: these subjects are rather uncommon;
the functional status of the nigro-striatal system can be accu-
rately assessed with the use of dopamine transporter imaging with
SPECT (decline of the uptake suggests the diagnosis of PD instead
of ET), which has become available in clinical practice in many
parts of the world (Marshall and Grosset, 2003); these patients can
be treated with a combination of the armamentarium used for the
two conditions.
DYSTONIC TREMOR
Until a few years ago there were few allusions to dystonic tremor
in the medical literature. In 1998 the Consensus Statement of the
Movement Disorder Society on Tremor made a note that“dystonic
tremor syndrome is still under debate and different definitions
have been proposed” and submitted a description and diagnostic
criteria for this entity: (1) tremor in an extremity or body part
that is affected by dystonia; (2) focal tremors, usually with irreg-
ular amplitudes and variable frequency (mainly less than 7 Hz);
(3) mainly postural/kinetic tremors and usually not seen during
complete rest (Deuschl et al., 1998).
The issue remained relatively dormant until a number of drug
studies enrolling patients with early stages of PD led to the descrip-
tion of the so-called “Scans without evidence of dopaminergic
deficit”(SWEDDs; Whone et al., 2003; Holloway et al., 2004; Marek
et al., 2005). All these studies, having in common the use of func-
tional imaging of the nigro-striatal system either using PET or
SPECT technology and the finding that between 11 and 15% of
the patients were SWEDDs. It seems clear now that these patients
did not have PD since long-term follow up failed to identify any
worsening of the clinical picture and l-DOPA has not improved
the tremor (Schneider et al., 2007). SWEDDs comprise a hetero-
geneous group of patients with a number of underlying causes:
dystonic tremor (79%), ET (3%), vascular parkinsonism (3%),
and indeterminate in 15% (Bajaj et al., 2012). There are recent
reports of genetic defects, such as mutations of GLUT1, presenting
with dystonic tremor (Roubergue et al., 2011). More recently, the
following features have been reported as characteristic of dystonic
tremor: dystonia (which may be subtle), thumb extension tremor,
“flurries” or task/position-specificity of tremor, head tremor, dys-
tonic voice, no progression to develop features other than tremor
and dystonia, and no clear fatiguing or decrement of repetitive
movements (Schneider et al., 2007).
It should be pointed out that the distinction of dystonic tremor
from ET is not always simple, with patients with the former being
diagnosed with the later (Quinn et al., 2011). This is an area
where more work is warranted: one of the problems of the cur-
rent concept of dystonic tremor is the admission that in some of
the patients “tremor is unilateral or very asymmetric, irregular or
jerky, position- or task-specific (and therefore more likely to be
disabling), relieved by a geste antagoniste, pronation-supination
rather than vertical, or occurring in flurries, but without (at least
yet) frank dystonia” (Quinn et al., 2011). Despite the fact that
the Consensus Statement of the Movement Disorder Society on
Tremor (Deuschl et al., 1998) considers isolated head tremor as
one feature of ET, clinical practice shows that this phenomenol-
ogy is almost invariably an expression of dystonia. Obviously,
the admission that dystonia may be absent contradicts the cur-
rent definition of dystonic tremor and, from a practical point
of view, renders the differentiation from ET extremely difficult.
One should bear in mind that in a few subjects, the clinical pic-
ture of dystonia can be dominated almost entirely by tremor with
dystonia remaining a very subtle finding. Finally, patients with
dystonic tremor often fail to respond to any available pharmaco-
logical treatment. It is also important to stress that one potential
difficulty in establishing dystonic tremor as a nosological entity
on its own is the lack of clinico-pathological studies of this con-
dition. To conclude, it is important to state that in the majority of
cases, the distinction between ET and dystonic tremor is readily
made. The scenarios discussed herein refer to a limited number of
patients.
DIFFERENTIAL DIAGNOSIS OF CHOREA IN CHILDREN
Sydenham’s Chorea (SC) accounts for nearly 100% of all cases of
chorea in children worldwide (Cardoso et al., 2006; Zomorrodi
and Wald, 2006). Typically, the gradual or subacute onset is in the
end of the first decade of life, being more frequent in girls than boys
and, unlike other manifestations of rheumatic fever, there is a long
latency between streptococcal pharyngitis and the development
of chorea. Consequently, many patients with SC fail to display
laboratory findings of acute infection or inflammatory reaction.
The clinical picture comprises motor findings with chorea, and
decreased muscle tone. Less common features are tics, present in
no more than 8% of subjects, hemichorea (20% of cases), and
chorea paralytica (the muscle tone is so decreased that patients are
unable to stand) in 8% of our series (Cardoso et al., 2006; de Teix-
eira et al., 2009). There are also non-motor findings that include
obsessions, compulsion, hyperactivity, attention deficit, headache,
dysexecutive syndrome and, rarely, psychosis (Maia et al., 2005;
Teixeira et al., 2005, 2007; Beato et al., 2010). Of note, disability
in SC is usually a result of cardiopathy, present in up to 80% of
subjects. Although in the majority of individuals SC comes into
remission by the end of the first year of illness, recurrences are
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seen in up to 20% of patients and persistence of chorea occurs in
25% of subjects (Cardoso et al., 1999).
There has been a steady decline of SC incidence even in areas
where it used to be frequent such as Latin America and Africa. This
is probably a result of improvement of public health conditions
but it may also represent a change in the biology of Streptococ-
cus. The bottom line is that there is a growing need to consider
diagnoses alternative to SC in children with chorea. The first dif-
ferential diagnosis to be considered is vascular chorea. The abrupt
onset, lack of behavioral abnormalities and other features sug-
gestive of rheumatic fever and, particularly, abnormal imaging
readily distinguish vascular chorea from SC (Cardoso et al., 2006).
A particular form of vascular chorea, which is uncommon in the
West and more often found in Asia, is moyamoya disease. It is
characterized by chronic stenoocclusive vasculopathy of the major
vessels of the circle of Willis and development of aberrant distal
vascular network (Weinberg et al., 2011). Although the most com-
mon clinical features are hemorrhage or ischemia, a few patients
may present with paroxysmal chorea. This clinical pattern together
with characteristic findings on magnetic resonance imaging and
angiography lead to the correct diagnosis (Baik and Lee, 2010).
Despite the finding that almost all cases of acute chorea in children
are caused by SC, there are instances where alternative diagnoses
should be considered. The most important differential diagnosis
of SC is chorea associated to systemic lupus erythematosus (SLE)
and primary antiphospholipid antibody syndrome (PAPS; Car-
doso et al., 2006). In classical forms, patients with SLE have chorea
combined with psychosis and extra-neurological features such as
rash skin, pericarditis, renal failure, and other organs involvement
as well as typical laboratory abnormalities (Reiner et al., 2011;
Baizabal-Carvallo and Jankovic, 2012). In PAPS, chorea is associ-
ated with headache, behavioral abnormalities, repeated abortion,
and thrombotic phenomena such as pulmonary embolism and
deep venous thrombosis (Baizabal-Carvallo and Jankovic, 2012).
In practice, however, the diagnosis can be challenging since chorea
can be the sole finding for a long period of time before the devel-
opment of other clinical and laboratory findings supportive of the
diagnosis of SLE or PAPS (Bakdash et al., 1999); chorea can be
a mild feature eclipsed by other findings particularly parkinson-
ism and myoclonus (Baizabal-Carvallo and Jankovic, 2012); the
recurrent nature of SLE and PAPS is also found in at least 1/5 of
patients with SC; SC lacks specific laboratory markers. There are
also other rare conditions that may mimic SC: vascular disease,
prescription and illicit drugs, genetic conditions such as Friedre-
ich’s ataxia and hereditary benign chorea (Cardoso et al., 2006).
The practical message is that one needs to be cautious when mak-
ing the diagnosis of SC, particularly in the absence of other features
of rheumatic fever. Patients always require comprehensive labora-
tory and imaging work up to rule out alternative causes. Finally,
clinicians should be attentive to the development of atypical fea-
tures, even after a long-term follow up, which may suggest SLE,
PAPS, or even other causes. Among these features are psychosis,
pyramidal signs, ataxia, and ophthalmoparesis.
CONCLUSION
In most instances, ET and PD are easily distinguishable. How-
ever, there is a small minority of patients with long duration
ET who develop parkinsonian features characterized mostly by
tremor at rest and rigidity with minor bradykinesia. Current
functional imaging, biochemical, and pathological data do not
support that these patients have PD. The mechanism underlying
parkinsonian features of these patients remains to be determined.
Dystonic tremor is an entity growingly diagnosed and regarded as
accounting for the majority of SWEDDs in drug trials. Its clinical
features, diagnostic criteria and etiology remain controversial and
ill-defined. Currently, it is described as the coexistence of tremor
and dystonia in a limb or neck. However, as in many reported cases
there is coexistent parkinsonian features and very mild dystonia,
clinical distinction from PD and even ET may be difficult. Further
studies are warranted to improve the accuracy of the diagnosis of
dystonic tremor. Finally, although SC is the cause of the majority
of acute chorea in children, in some patients SLE or PAPS causes
this movement disorder. It is important to keep in mind that not
infrequently there is a rather long latency until patients develop
clinical and laboratory features that define the diagnosis of these
two conditions.
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